在质母细胞瘤中,ELAVL2损失促进了激进的介质细胞过渡
Yona Kim1,2, Ji Hyeon You1,3, Yeonjoo Ryu1,2
1Department of Neurosurgery, Cancer Research Institute and Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul, Korea.
NPJ precision oncology
|March 29, 2024
概括
RNA结合蛋白 ELAVL2 作为质母细胞瘤 (GBM) 的瘤抑制剂. ELAVL2的丧失促进了侵袭性癌症特征和化疗耐药性,而它的存在提高了患者的生存率.
科学领域:
- 神经瘤学神经瘤学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 质母细胞瘤 (GBM) 是一种具有异质性和可塑性特征的侵袭性脑癌.
- 介质细胞 (MES) 过渡是GBM攻击性和治疗耐药性的关键驱动因素.
- GBM可塑性的调节机制,特别是MES过渡,尚未完全理解.
研究的目的:
- 调查RNA结合蛋白ELAVL2在调节质母细胞瘤中介酶转换中的作用.
- 了解GBM中ELAVL2变化的临床和分子影响.
主要方法:
- 转录组分析以评估ELAVL2介导的基因表达变化.
- 在GBM细胞中进行功能测试,以评估ELAVL2表达对MES过渡和化疗耐药性的影响.
- 组织微阵列分析以将ELAVL2蛋白水平与患者存活率相关联.
- RNA免疫沉试验用于识别ELAVL2.2的直接标.
主要成果:
- 在GBM中,ELAVL2经常被删除,并与明显的临床特征相关.
- ELAVL2的表达与表皮细胞转化为介质细胞转化 (EMT) 基因有负相关性;其损失促进了MES转化和化疗抵抗.
- 患者的高ELAVL2蛋白表达预测了有利的生存结果.
- ELAVL2直接与SH3GL3和DNM3转录物结合,通过一种m6A依赖机制潜在地稳定它们.
结论:
- 在质母细胞瘤中,ELAVL2作为关键瘤抑制剂起作用.
- ELAVL2通过稳定特定的mRNA点来调节GBM中的转录基因可塑性和介质细胞过渡.
- ELAVL2是改善质母细胞瘤治疗结果的潜在治疗标.
相关概念视频
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:12Loss of Tumor Suppressor Gene Functions
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:12Loss of Tumor Suppressor Gene Functions
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...